[Treatment of severe recurrent laryngotracheal papillomatosis with tracheobronchial stent].

Recurrent respiratory papillomatosis is a chronic airway disease that occurs in both children and adults. It is caused by the human papillomavirus, more than 90% by HPV types 6 and HPV 11. The clinical presentation is nonspecific and most patients present with hoarseness, stridor or dyspnea. Although there is no definitive treatment, the objective focuses on improving voice quality and maintaining airway patency, in our case it was achieved through the placement of a Y-shaped stent placed in airway added to adjuvant treatment with Bevacizumab. Surgical management is the mainstay of treatment and around 20% of patients benefit from adjuvant therapies.